Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • generic

    Tag: generic

    You Searched For "generic"
    Lupin gets USFDA nod for generic contraceptive tablets

    Lupin gets USFDA nod for generic contraceptive tablets

    Ruby Khatun Khatun15 Dec 2017 10:30 AM IST
    New Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
    Panacea Biotec gets USFDA nod to file for generic cancer drug

    Panacea Biotec gets USFDA nod to file for generic cancer drug

    Ruby Khatun Khatun2 Dec 2017 10:00 AM IST
    New Delhi: Panacea Biotec said the US health regulator has accepted its filing for approval of generic version of cancer treatment injection...
    Teva

    Teva's new CEO shakes up management, to combine divisions

    Ruby Khatun Khatun30 Nov 2017 9:15 AM IST
    TEL AVIV: Teva Pharmaceutical Industries Ltd's new chief executive officer ousted the company's three top division heads on Monday as he works to turn...
    Ajanta Pharma launches generic ADHD treatment drug in US

    Ajanta Pharma launches generic ADHD treatment drug in US

    Ruby Khatun Khatun23 Nov 2017 10:15 AM IST
    New Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
    Hetero gets DCGI nod to market anti-retroviral FDC tablets

    Hetero gets DCGI nod to market anti-retroviral FDC tablets

    Ruby Khatun Khatun17 Nov 2017 10:45 AM IST
    New Delhi: Drug firm Hetero said it has received the Drug Controller General of India's approval to launch generic fixed-dose combination...
    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Ruby Khatun Khatun4 Oct 2017 10:55 AM IST
    New Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
    FDA acts to encourage generic competition for complex drugs

    FDA acts to encourage generic competition for complex drugs

    Ruby Khatun Khatun4 Oct 2017 10:46 AM IST
    TRENTON, N.J.: The U.S. Food and Drug Administration (FDA) is opening a new front in its efforts to reduce high drug prices by encouraging the...
    Glenmark gets USFDA nod for chest pain tablets

    Glenmark gets USFDA nod for chest pain tablets

    Ruby Khatun Khatun22 Sept 2017 10:47 AM IST
    New Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
    Strides Shasun gets USFDA nod for lipid lowering drug

    Strides Shasun gets USFDA nod for lipid lowering drug

    Ruby Khatun Khatun21 Sept 2017 10:49 AM IST
    New Delhi: Drug firm Strides Shasun on Wednesday said it has received approval from the United States health regulator for generic Omega-3-acid ethyl...
    Fosun Pharma to buy 74 percent stake in Gland Pharma for 1.1 billion dollar

    Fosun Pharma to buy 74 percent stake in Gland Pharma for 1.1 billion dollar

    Ruby Khatun Khatun19 Sept 2017 10:47 AM IST
    BEIJING/MUMBAI: Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 percent for $1.1...
    Lupin appoints Jim Loerop as Chief Corporate Development Officer

    Lupin appoints Jim Loerop as Chief Corporate Development Officer

    Ruby Khatun Khatun19 Sept 2017 10:29 AM IST
    Mumbai: Pharma Major Lupin announced the appointment of Jim Loerop as Chief Corporate Development Officer. Jim will lead Lupin's overall corporate...
    Glenmark gets USFDA approval for Rythmol SR generic

    Glenmark gets USFDA approval for Rythmol SR generic

    Ruby Khatun Khatun13 Sept 2017 2:08 PM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok